Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$296,936
+$93,765 QoQ
Shares Held
21,979
+34.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Allworth Financial LP holds $13,612,825 across 48 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
65,808 | $7,779,163 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
46,558 | $2,406,583 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,507 | $1,120,712 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,083 | $642,197 | |
| 5 | VTRS |
Viatris Inc
This page
|
21,979 | $296,936 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
12,733 | $235,815 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
16,116 | $223,206 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
8,810 | $210,823 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $296,936 | 21,979 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $203,171 | 16,319 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $181,368 | 18,320 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $129,422 | 14,493 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $87,526 | 10,049 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $80,252 | 6,446 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $78,321 | 6,746 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $60,845 | 5,724 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $53,741 | 4,501 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $50,466 | 4,660 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $49,693 | 5,040 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $53,253 | 5,336 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $50,552 | 5,255 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $46,723 | 4,198 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $35,903 | 4,214 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $30,750 | 2,937 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $56,173 | 5,163 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $41,388 | 3,059 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $53,807 | 3,971 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $44,899 | 3,142 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $48,196 | 3,450 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $54,420 | 2,904 | Shares | Sole | 2021-01-26 | |
| No filing history on record for this holder in this stock. | ||||||